Skip to main content
. 2020 Nov 19;18(11):570. doi: 10.3390/md18110570
TCMs traditional Chinese medicines
OTMs other traditional medicines
Hc Hemocyanin
COPD chronic obstructive pulmonary disease
ARDS acute respiratory distress syndrome
NSAIDs non-steroidal anti-inflammatory drugs
MIC/MBC minimum inhibitory/bactericidal concentration
IC50/GI50/CC50 concentration causing 50% inhibition/growth inhibition/cytotoxicity
PUFAs polyunsaturated fatty acids
FDA United States Food and Drug Administration
Abs antibodies